Ultrasonography.
2023 Jul;42(3):388-399. 10.14366/usg.23065.
Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
- Affiliations
-
- 1Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan
- 2Ultrasound Division, GE HealthCare, Hino, Tokyo, Japan
- KMID: 2543375
- DOI: http://doi.org/10.14366/usg.23065
Abstract
- This review outlines several modified versions of the contrast-enhanced ultrasonography Liver Imaging Reporting and Data System (CEUS LI-RADS) that utilize Sonazoid. Furthermore, it discusses the advantages and challenges of diagnosing hepatocellular carcinoma using these guidelines, as well as the authors’ expectations and opinions regarding the next CEUS LI-RADS version. It is possible that Sonazoid could be incorporated into the next version of CEUS LI-RADS.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma
- Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
- Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
- Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
- Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
